Skip to content
The Policy VaultThe Policy Vault

Revlimid — Medica

Primary Central Nervous System Lymphoma

Initial criteria

  • EITHER (a) relapsed or refractory disease OR (b) patient not a candidate for or intolerant to high-dose methotrexate

Approval duration

1 year